Proteine mit Einfluss auf die Blutgerinnung [Proteins influencing the blood coagulation].

Détails

ID Serval
serval:BIB_F1B74A5287C3
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Titre
Proteine mit Einfluss auf die Blutgerinnung [Proteins influencing the blood coagulation].
Périodique
Therapeutische Umschau. Revue Thérapeutique
Auteur⸱e⸱s
Alberio L.
ISSN
0040-5930 (Print)
ISSN-L
0040-5930
Statut éditorial
Publié
Date de publication
2011
Peer-reviewed
Oui
Volume
68
Numéro
11
Pages
631-640
Langue
allemand
Notes
Publication types: English Abstract ; Journal Article ; Review Publication Status: ppublish
Résumé
This review describes some natural proteins, which can be employed, either as factor concentrates derived from human plasma or as recombinant drug, to modulate the coagulation system. I will address some biochemical characteristics and the physiological role of von Willebrand factor, the coagulation factors of the extrinsic and intrinsic pathways, and the physiological anticoagulant protein C. In addition, I will detail the pharmacological compounds, which are available for influencing or substituting the coagulation proteins: desmopressin (DDAVP), single coagulation factor concentrates, prothrombin complex concentrates, and protein C concentrate. In particular, I will address some treatment topics of general medical interest, such as the treatment of massive bleeding, the correction of the coagulopathy induced by vitamin K-antagonists in patients with cerebral haemorrhage, and of the coagulopathy of meningococcemia. Finally, I will describe some properties and practical clinical applications of the recombinant anticoagulans lepirudin and bivalirudin, which are derived from hirudin, the natural anticoagulant of the medical leech.
Mots-clé
Anticoagulants/adverse effects, Anticoagulants/therapeutic use, Blood Coagulation Disorders/blood, Blood Coagulation Disorders/drug therapy, Blood Coagulation Factors/adverse effects, Blood Coagulation Factors/therapeutic use, Blood Proteins/adverse effects, Blood Proteins/therapeutic use, Cerebral Hemorrhage/blood, Cerebral Hemorrhage/chemically induced, Hemorrhage/blood, Hemorrhage/drug therapy, Hirudins/adverse effects, Humans, Peptide Fragments/adverse effects, Peptide Fragments/therapeutic use, Protein C/adverse effects, Protein C/therapeutic use, Recombinant Proteins/adverse effects, Recombinant Proteins/therapeutic use, Vitamin K/antagonists & inhibitors, von Willebrand Factor/adverse effects, von Willebrand Factor/therapeutic use
Pubmed
Création de la notice
10/02/2015 12:13
Dernière modification de la notice
20/08/2019 17:19
Données d'usage